相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cutaneous immunology: basics and new concepts
Amir S. Yazdi et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Psoriasin (S100A7) promotes stress-induced angiogenesis
J. Vegfors et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Topically Used Herbal Products for the Treatment of Psoriasis - Mechanism of Action, Drug Delivery, Clinical Studies
Anna Herman et al.
PLANTA MEDICA (2016)
α- and β-Santalols Directly Interact with Tubulin and Cause Mitotic Arrest and Cytotoxicity in Oral Cancer Cells
Brigette Lee et al.
JOURNAL OF NATURAL PRODUCTS (2015)
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials
Richard G. B. Langley et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Philip J. Mease et al.
DRUGS (2014)
Suppression of Lipopolysaccharide-stimulated Cytokine/Chemokine Production in Skin Cells by Sandalwood Oils and Purified -santalol and -santalol
M. Sharma et al.
PHYTOTHERAPY RESEARCH (2014)
JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
Leeyen Hsu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis
Shiqiang Deng et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
W. C. Ports et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
New therapies under development for psoriasis treatment
Martha-Estrella Garcia-Perez et al.
CURRENT OPINION IN PEDIATRICS (2013)
Amygdalin analogs for the treatment of psoriasis
Juan J. Perez
FUTURE MEDICINAL CHEMISTRY (2013)
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
Sarita Saraswati et al.
MOLECULAR CANCER (2013)
Promising New Treatments for Psoriasis
Sarah Dubois Declercq et al.
SCIENTIFIC WORLD JOURNAL (2013)
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Peter Schafer
BIOCHEMICAL PHARMACOLOGY (2012)
Antimicrobial peptides in the pathogenesis of psoriasis
Shin Morizane et al.
JOURNAL OF DERMATOLOGY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
Kim Papp et al.
LANCET (2012)
In touch with psoriasis: topical treatments and current guidelines
G. Murphy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents
Wolfgang Weger
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Novel investigational drugs for basal cell carcinoma
Po-Lin So et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Topical treatment of psoriasis
Philip M. Laws et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Shinji Kagami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Topical corticosteroids in psoriasis: strategies for improving safety
E. J. Horn et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Angiogenesis drives psoriasis pathogenesis
Regina Heidenreich et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
The Antimicrobial Protein Psoriasin (S100A7) Is Upregulated in Atopic Dermatitis and after Experimental Skin Barrier Disruption
Regine Glaeser et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
K. E. Nograles et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Safety assessment of sandalwood oil (Santalum album L.)
George A. Burdock et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics
Alice Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A role for T cell-derived interleukin 22 in psoriatic skin inflammation
K. Boniface et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Interleukin-17 in inflammatory skin disorders
Astrid J. van Beelen et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Nicholas J. Wilson et al.
NATURE IMMUNOLOGY (2007)
Psoriasis 2 - Current and future management of psoriasis
Alan Menter et al.
LANCET (2007)
Pathogenesis and therapy of psoriasis
Michelle A. Lowes et al.
NATURE (2007)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Chemopreventive effects of α-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice
Chandradhar Dwivedi et al.
CARCINOGENESIS (2006)
New antitumor sesquiterpenoids from Santalum album of Indian origin
Tae Hoon Kim et al.
TETRAHEDRON (2006)
Glucocorticoid therapy-induced skin atrophy
S Schoepe et al.
EXPERIMENTAL DERMATOLOGY (2006)
Review of a treatment for psoriasis using herose, a botanical formula
TT Yuqi
JOURNAL OF DERMATOLOGY (2005)
Anti-Helicobacter pylori compounds from Santalum album
T Ochi et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Psoriasis treatment: traditional therapy
M Lebwohl et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Skin cancer chemopreventive agent, α-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release
M Kaur et al.
CARCINOGENESIS (2005)
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
GD Weinstein et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
分享论文
